These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37868962)

  • 1. CD4
    Jeyamogan S; Leventhal JR; Mathew JM; Zhang ZJ
    Front Immunol; 2023; 14():1270300. PubMed ID: 37868962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascularized composite allotransplantation versus solid organ transplantation: innate-adaptive immune interphase.
    Kadono K; Gruszynski M; Azari K; Kupiec-Weglinski JW
    Curr Opin Organ Transplant; 2019 Dec; 24(6):714-720. PubMed ID: 31577596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts.
    Abe Y; Urakami H; Ostanin D; Zibari G; Hayashida T; Kitagawa Y; Grisham MB
    PLoS One; 2009 Nov; 4(11):e7840. PubMed ID: 19956764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thrombin on endothelium enhances recruitment of regulatory T cells during IRI and when combined with adoptive Treg transfer, significantly protects against acute tissue injury and prolongs allograft survival.
    Peng Q; Nowocin A; Ratnasothy K; Smith RA; Smyth LA; Lechler RI; Dorling A; Lombardi G
    Front Immunol; 2022; 13():980462. PubMed ID: 36793549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury.
    Kinsey GR; Sharma R; Huang L; Li L; Vergis AL; Ye H; Ju ST; Okusa MD
    J Am Soc Nephrol; 2009 Aug; 20(8):1744-53. PubMed ID: 19497969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presensitized immune condition of host exaggerates prolonged cold ischemia-mediated injury of cardiac graft involving regulatory T cells.
    Gong W; Huang T; Ge F; Luo G; Yuan S; Gao D; Kong D
    Transplantation; 2013 Oct; 96(7):609-15. PubMed ID: 23880577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Effect of CXCR3⁺CD4⁺CD25⁺Foxp3⁺ Regulatory T Cells in Renal Ischemia-Reperfusion Injury.
    Jun C; Qingshu L; Ke W; Ping L; Jun D; Jie L; Su M
    Mediators Inflamm; 2015; 2015():360973. PubMed ID: 26273136
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lei B; Sleiman MM; Cheng Q; Tu Z; Zhu P; Goddard M; Martins PN; Langerude L; Nadig S; Tomlinson S; Atkinson C
    Front Immunol; 2021; 12():630581. PubMed ID: 34394069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of CD4(+)CD25(high)CD127(low) regulatory T cells in renal ischemia-reperfusion injury.
    Jun C; Ke W; Qingshu L; Ping L; Jun D; Jie L; Bo C; Su M
    Cell Immunol; 2014; 289(1-2):106-11. PubMed ID: 24754976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy.
    Lin CH; Zhang W; Ng TW; Zhang D; Jiang J; Pulikkottil B; Lakkis F; Gorantla VS; Lee WP; Brandacher G; Zheng XX
    Am J Transplant; 2013 Aug; 13(8):2161-8. PubMed ID: 23718897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of regulatory T cells supports the development of intestinal ischemia-reperfusion injuries.
    Yang X; Bai H; Wang Y; Li J; Zhou Q; Cai W; Han J; Zhu X; Dong M; Hu D
    J Surg Res; 2013 Oct; 184(2):832-7. PubMed ID: 23731680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic CD11c
    Wang P; Li C; Peng T; Ruan L; Wu A; Zhu J; Shi W; Chen M; Zhang T
    FASEB J; 2024 Mar; 38(6):e23575. PubMed ID: 38530256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.
    He J; Khan UZ; Qing L; Wu P; Tang J
    Front Immunol; 2022; 13():998952. PubMed ID: 36189311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection.
    Krustrup D; Madsen CB; Iversen M; Engelholm L; Ryder LP; Andersen CB
    Transpl Immunol; 2013 Dec; 29(1-4):71-5. PubMed ID: 23969200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.
    Dashkevich A; Raissadati A; Syrjälä SO; Zarkada G; Keränen MA; Tuuminen R; Krebs R; Anisimov A; Jeltsch M; Leppänen VM; Alitalo K; Nykänen AI; Lemström KB
    Am J Transplant; 2016 Apr; 16(4):1160-72. PubMed ID: 26689983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shikonin Prolongs Allograft Survival via Induction of CD4
    Zeng Q; Qiu F; Chen Y; Liu C; Liu H; Liang CL; Zhang Q; Dai Z
    Front Immunol; 2019; 10():652. PubMed ID: 30988670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance.
    Hu M; Wang C; Zhang GY; Saito M; Wang YM; Fernandez MA; Wang Y; Wu H; Hawthorne WJ; Jones C; O'Connell PJ; Sparwasser T; Bishop GA; Sharland AF; Alexander SI
    Am J Transplant; 2013 Nov; 13(11):2819-30. PubMed ID: 24102948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioimaging of alloantigen-stimulated regulatory T cells in rat vascularized composite allotransplantation.
    Cheng HY; Tay SKL; Wen CJ; Lin CF; Wang AY; Shih LY; Liu SC; Kobayashi E; Lin CH; Wei FC
    PLoS One; 2018; 13(9):e0203624. PubMed ID: 30192879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
    Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
    Front Immunol; 2021; 12():716559. PubMed ID: 34335631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.